Insider Trading & Ownership - Smither John W

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Smither John W
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-29
Purchase
2024-06-07
9:45 pm
GENELUX CorpGNLXSmither John W
Director
6,250$0$019,420
(Direct)
View
2023-09-13
Sale
2023-09-14
8:18 pm
GENELUX CorpGNLXSmither John W
Director
900$20.78$18,7026,920
(Direct)
View
2021-03-10
Sale
2021-03-11
3:59 pm
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
1,750$32.9$57,575178,018
(Indirect
Direct)
View
2021-03-01
Sale
2021-03-03
4:48 pm
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
773$34.2$26,440112,390
(Indirect
Direct)
View
2021-02-10
Sale
2021-02-12
5:32 pm
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
2,750$35.64$98,010158,645
(Indirect
Direct)
View
2021-02-01
Sale
2021-02-03
11:23 am
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
5,000$35$175,000161,395
(Indirect
Direct)
View
2021-01-19
Sale
2021-01-21
4:41 pm
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
1,750$30$52,500166,395
(Indirect
Direct)
View
2020-12-14
Sale
2020-12-16
3:14 pm
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
5,250$30$157,500168,145
(Indirect
Direct)
View
2020-09-29
Sale
2020-10-01
9:00 pm
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
1,750$30$52,500172,072
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-01
Option Award
2024-08-05
6:34 pm
N/A
2034-07-31
GENELUX CorpGNLXSmither John W
Director
90,010$0103,180
(Direct)
View
2024-02-13
Option Award
2024-02-15
6:23 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
11,365$0152,757
(Direct)
View
2024-02-13
Disposition
2024-02-15
6:23 pm
N/A
2025-03-31
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
34,097$0152,757
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:13 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSSmither John W
Director
10,000$010,000
(Direct)
View

Ownership
2023-12-29
4:30 pm
N/A
2033-01-14
NewAmsterdam Pharma Co N.V.NAMSSmither John W
Director
0$018,600
(Direct)
View
2023-12-27
Disposition
2023-12-28
5:38 pm
N/A
2032-01-27
Applied Molecular Transport Inc.AMTISmither John W
Director
100,000$00
(Direct)
View
2023-09-11
Option Award
2023-09-13
8:14 pm
N/A
2033-09-10
GENELUX CorpGNLXSmither John W
Director
15,367$016,267
(Direct)
View

Ownership
2023-09-13
8:13 pm
N/A
N/A
GENELUX CorpGNLXSmither John W
Director
0$0900
(Direct)
View
2023-08-31
Option Award
2023-09-05
9:38 pm
N/A
2033-08-31
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
125,000$0125,000
(Direct)
View

Ownership
2023-09-05
9:36 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
0$0253,738
(Indirect)
View
2023-06-22
Option Award
2023-06-22
8:16 pm
N/A
2033-06-21
eFFECTOR Therapeutics Inc.EFTRSmither John W
Director
20,000$020,000
(Direct)
View
2023-06-14
Option Award
2023-06-15
5:28 pm
N/A
2033-06-14
Applied Molecular Transport Inc.AMTISmither John W
Director
20,000$020,000
(Direct)
View
2023-01-20
Option Award
2023-01-24
4:15 pm
N/A
2033-01-19
eFFECTOR Therapeutics Inc.EFTRSmither John W
Director
36,875$036,875
(Direct)
View
2022-06-09
Option Award
2022-06-13
6:51 pm
N/A
2032-06-08
eFFECTOR Therapeutics Inc.EFTRSmither John W
Director
20,000$020,000
(Direct)
View
2022-05-24
Option Award
2022-05-26
5:23 pm
N/A
2032-05-24
Applied Molecular Transport Inc.AMTISmither John W
Director
20,000$020,000
(Direct)
View
2022-01-27
Option Award
2022-01-31
5:39 pm
2022-02-27
2032-01-27
Applied Molecular Transport Inc.AMTISmither John W
Director
60,000$060,000
(Direct)
View
2021-10-06
Option Award
2021-10-08
5:18 pm
N/A
2031-10-05
eFFECTOR Therapeutics Inc.EFTRSmither John W
Director
40,000$040,000
(Direct)
View
2021-08-25
Option Award
2021-08-27
6:26 pm
N/A
2028-03-26
eFFECTOR Therapeutics Inc.EFTRSmither John W
Director
27,698$051,840
(Direct)
View
2021-03-10
Exercise
2021-03-11
3:59 pm
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
500$0178,018
(Direct)
View
2021-03-10
Exercise
2021-03-11
3:59 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
500$1.6806178,018
(Direct)
View
2021-03-04
Exercise
2021-03-05
3:55 pm
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
12,396$0260,770
(Direct)
View
2021-03-04
Exercise
2021-03-05
3:55 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
12,396$1.6806260,770
(Direct)
View
2021-03-03
Option Award
2021-03-05
3:55 pm
N/A
2031-03-03
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
38,300$0260,770
(Direct)
View
2021-02-10
Exercise
2021-02-12
5:32 pm
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
750$0158,645
(Direct)
View
2021-02-10
Exercise
2021-02-12
5:32 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
750$1.6806158,645
(Direct)
View
2021-02-01
Exercise
2021-02-03
11:23 am
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
1,250$0161,395
(Direct)
View
2021-02-01
Exercise
2021-02-03
11:23 am
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
1,250$1.6806161,395
(Direct)
View
2021-01-19
Exercise
2021-01-21
4:41 pm
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
500$0166,395
(Direct)
View
2021-01-19
Exercise
2021-01-21
4:41 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
500$1.6806166,395
(Direct)
View
2020-12-14
Exercise
2020-12-16
3:14 pm
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
1,500$0168,145
(Direct)
View
2020-12-14
Exercise
2020-12-16
3:14 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
1,500$1.6806168,145
(Direct)
View
2020-09-29
Exercise
2020-10-01
9:00 pm
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
500$0172,072
(Direct)
View
2020-09-29
Exercise
2020-10-01
9:00 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
500$1.6806172,072
(Direct)
View
2020-06-11
Exercise
2020-06-15
3:15 pm
N/A
2029-05-14
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
14,875$0233,920
(Direct)
View
2020-06-11
Exercise
2020-06-15
3:15 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
14,875$1.6806233,920
(Direct)
View
2020-02-27
Option Award
2020-03-03
9:09 pm
N/A
2030-02-27
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
21,000$0120,965
(Direct)
View

Ownership
2020-01-30
8:00 pm
N/A
N/A
Arcutis Biotherapeutics Inc.ARQTSmither John W
Chief Financial Officer
0$0289,896
(Direct)
View